Highbridge Capital Management »

Protalix Biotherapeutics shares owned by Highbridge Capital Management

Quarter-by-quarter ownership of Protalix Biotherapeutics shares owned by Highbridge Capital Management from 13F filings

Historical chart of Highbridge Capital Management investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Highbridge Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $15B 13M 1185.00
2023-09-30 $145k 13M 0.01
2023-06-30 $15M 13M 1.20
2023-03-31 $180k 15M 0.01
2022-12-31 $16M 15M 1.04
2022-06-30 $15M 15M 1.02
2022-03-31 $17M 15M 1.16
2021-12-31 $14M 15M 0.94

Top funds holding Protalix Biotherapeutics